("IPF plc" or the "Company") ...Grant of 367,447 shares under the IPF Restricted SharePlan ... a) Grant of 213,384 shares under the IPF Restricted Share Plan ... (a) Grant of 88,911 shares under the IPF Restricted Share Plan.
Pooled patients treated with TTI-101 demonstrated a 9.4% decrease from baseline in fibrosis score at week 12, compared to a 2.4% decrease for the placebo group ... .
Everything's now ready for the 18th edition of IPFBangladesh (Dhaka, 28 - 31 January 2026), where SACMI cap- and preform-making solutions will again take centre-stage ... Visit the SACMI stand at IPF Bangladesh 2026.
Under the terms of the Further Revised Possible Offer, IPF shareholders would be entitled to receive 235 pence in cash per IPF share and eligible IPF shareholders would also be to entitled to retain ...
... GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis ("IPF") ... We look forward to watching the clinical advancement of GRI-0621 as a potential treatment for patients with IPF.".
DelveInsight delivered comprehensive conference coverage across major respiratory events to support a client developing an IPF therapy ... The GrowingUrgency in IPF Research ... A Multi-Layered Approach to Capturing IPF Intelligence.
International Personal Finance plc ("IPF" or the "Group") is helping to build a better world through financial inclusion by providing unsecured consumer credit to underserved consumers across nine markets.